Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital

[1] Falagas ME(2006)Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections Clin Microbiol Infe 12 1227-1230

[2] Rafailidis PI(2009)Use of colistin in children Pediatr infect Dis J 28 534-535

[3] Kasiakou SK(2008)Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology Clin infect Dis 46 1121-1122

[4] Hatzopoulou P(2007)Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population J Burn Care Res 28 421-426

[5] Michalopoulos A(2008)Clinical and economic impact of common multidrug-resistant gram-negative bacilli Antimicrob Agents Chemother 52 813-821

[6] Tamma PD(2008)Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock Ind J Crit Care Med 12 153-157

[7] Lee CK(2010)Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients Pediatr Int 52 410-414

[8] Falagas ME(2009)Systemic colistin use in children without cystic fibrosis: a systematic review of the literature Int J Antimicrob Agents 33 503-874

[9] Karageorgopoulos DE(2010)Colistin administration to pediatric and neonatal patients Eur J Pediatr 169 867-615

[10] Goverman J(2009)Use of colistin in a pediatric burn unit in Argentina J Burn Care Res 30 612-144

[1] Falagas ME(2006)Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections Clin Microbiol Infe 12 1227-1230

[2] Rafailidis PI(2009)Use of colistin in children Pediatr infect Dis J 28 534-535

[3] Kasiakou SK(2008)Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology Clin infect Dis 46 1121-1122

[4] Hatzopoulou P(2007)Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population J Burn Care Res 28 421-426

[5] Michalopoulos A(2008)Clinical and economic impact of common multidrug-resistant gram-negative bacilli Antimicrob Agents Chemother 52 813-821

[6] Tamma PD(2008)Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock Ind J Crit Care Med 12 153-157

[7] Lee CK(2010)Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients Pediatr Int 52 410-414

[8] Falagas ME(2009)Systemic colistin use in children without cystic fibrosis: a systematic review of the literature Int J Antimicrob Agents 33 503-874

[9] Karageorgopoulos DE(2010)Colistin administration to pediatric and neonatal patients Eur J Pediatr 169 867-615

[10] Goverman J(2009)Use of colistin in a pediatric burn unit in Argentina J Burn Care Res 30 612-144